LOGIN  |  REGISTER
Cue Biopharma
Amneal Pharmaceuticals

Nova Leap Health announces Closing of Strategic Acquisition in Florida

December 16, 2024 | Last Trade: C$0.25 0.00 0.00

HALIFAX, Nova Scotia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a growing home health care organization, is pleased to announce that it has completed the strategic acquisition of a home care business with operations in Florida. The execution of the definitive agreement and related information pertaining to this acquisition was previously announced on October 15, 2024 and October 29, 2024.

“We’re pleased to enter the Florida market,” said Chris Dobbin, President & CEO of Nova Leap. “We like the long-term prospects for the market and we’re looking forward to working with the existing management team as we plan further expansion.”

The acquisition was a Non-Arm’s Length transaction pursuant to TSX Venture Exchange (“TSXV”) policies and was approved by written consent of disinterested shareholders of the Company under TSXV policies.

About Nova Leap

Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 and #2 ranking on the 2021 and 2020 Report on Business ranking of Canada’s Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 8 different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.

FORWARD LOOKING INFORMATION

Certain information in this press release may contain forward-looking statements. This information is based on current expectations and assumptions, including assumptions described elsewhere in this release and those concerning general economic and market conditions, availability of working capital necessary for conducting Nova Leap’s operations, availability of desirable acquisition targets and financing to fund such acquisitions, and Nova Leap’s ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include staff and supply shortages, regulatory changes affecting the home care industry or government programs utilized by the Company, other unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future, and these statements may not be appropriate for other purposes. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at www.sedarplus.com.

For further information:
Chris Dobbin, CPA, ICD.D
Director, President and CEO

CAUTIONARY STATEMENT

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB